Authors
Loading...
Review highlights microRNA dysregulation across diverse human diseases, suggesting therapeutic promise contingent on overcoming targeted viral and non-viral delivery hurdles.
Kenneth Lundström (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: